Paul Herendeen has been appointed as the new executive vice president and chief financial officer ofZoetis ( $ZTS ), the animal health industry leader. Reporting to CEO Juan Ramón Alaix, he will oversee the company's finance and IT segments. He ... FiercePharma, 1 month ago
New finance chief at Zoetis - Seeking Alpha, 1 month ago
Zoetis appoints executive vice president and CFO - Individual.com, 3 weeks ago
More from: CNBC, Stock Nod...and 41 other sources
1 images for "warner chilcott"
Written on Thu, 08/07/2014 - 6:18pm By Shiri Gupta SmarTrend identified an Uptrend for Warner Chilcott ( NASDAQ:WCRX ) on January 17th, 2013 at $13.53. In approximately 19 months, Warner Chilcott has returned 69.54% as of today's recent price ...Comtex SmarTrend, 1 month ago
Results were boosted by the inclusion of products from the Warner Chilcott acquisition. Quarterly Details Actavis has two revenue producing segments -- Actavis Pharma and Anda Distribution. While Actavis Pharma includes all branded, branded ...Nasdaq, 1 month ago
Brand manufacturer Mayne Pharma and the U.S. marketer of Mayne's acne drug Doryx, Warner Chilcott, have moved to settle class action claims with third party purchasers that allege the two companies inappropriately delayed generic competition on the ...FDA News, 1 month ago
A federal judge has tossed out all claims in a consolidated class-action antitrust lawsuit alleging that brandmaker Warner Chilcott executed a reverse payment to generics firms Watson (now Actavis) and Lupin Pharmaceuticals to delay generic ...FDA News, 1 week ago
Generic-drugmaker Actavis (NYSE: ACT ) has moved its headquarters to Ireland and is trying to develop its own branded drugs to cut costs and boost revenue. The company, formerly known as Watson Pharmaceuticals, boasts five straight quarters of ...Investor's Business Daily, 5 hours ago Actavis reports 2nd-qtr revenues increase by over a third Pharma Letter, 1 month ago Actavis Net Revenue Increases 34% to $2.67 Billion in Second Quarter 2014; Non-GAAP EPS Increases 70% to $3.42 Benzinga.com, 1 month ago
At the Morgan Stanley Global Healthcare Conference on September 9, Merck CEO Ken Frazier told investors he wouldn't join the giant wave of companies pursuing overseas acquisitions so they can move abroad and escape high U.S. corporate taxes. Such ...The Fiscal Times, 9 hours ago Capital Flight: Can Tax Inversions Be Prevented? Wharton, 3 days ago Merck's Frazier disses tax inversion strategy, at least for Merck FiercePharma, 1 week ago
The following are the M&A deals, rumors and chatter circulating on Wall Street for Friday September 12 through Sunday September 14, 2014: Google Rumored to be Taking Up to 40% Stake in Ebay The Rumor: Shares of Ebay, Inc. (NASDAQ: EBAY) surged ...Benzinga.com, 5 days ago
Bank of America has lost one of its top deal bankers to Barclays as the British bank looks to continue its success in the M&A advisory business Page 1 of 2 Published: September 10, 2014 at 4:22 pm EST By: Troy Kuhn Click Ticker to See live ...Bidness Etc, 1 week ago Barclays Appoints Top BofA Banker To Head Its M&A Structuring : FT RTTNews.com, 1 week ago
On Thursday, September 4, the US District Court in Rhode Island held that FTC v. Actavis, 133 S. Ct. 2223 (2013) requires a monetary payment from the patent owner to the potential generic challenger to support a so-called reverse payment claim, ...Lexology, 1 week ago
on your WebpageAdd Widget >Get your members hooked!